Rapid Dose Therapeutics Corp. (DOSE.CN)
CAD 0.2
(0.0%)
CAD 0.2
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.02 Million CAD | 42.06% |
| 2022 | 718.29 Thousand CAD | -59.0% |
| 2021 | 1.75 Million CAD | 566.62% |
| 2020 | 262.8 Thousand CAD | 158.93% |
| 2019 | 101.49 Thousand CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 515.91 Thousand CAD | 29.3% |
| 2024 Q1 | 398.99 Thousand CAD | 107.11% |
| 2023 Q3 | 233.81 Thousand CAD | -33.8% |
| 2023 FY | 1.02 Million CAD | 42.06% |
| 2023 Q1 | 240.78 Thousand CAD | 10.78% |
| 2023 Q2 | 353.17 Thousand CAD | 46.67% |
| 2023 Q4 | 192.65 Thousand CAD | -17.6% |
| 2022 Q4 | 217.34 Thousand CAD | -28.88% |
| 2022 Q1 | 61.76 Thousand CAD | -92.63% |
| 2022 Q2 | 133.55 Thousand CAD | 116.23% |
| 2022 FY | 718.29 Thousand CAD | -59.0% |
| 2022 Q3 | 305.62 Thousand CAD | 128.84% |
| 2021 FY | 1.75 Million CAD | 566.62% |
| 2021 Q1 | 131.19 Thousand CAD | -1.0% |
| 2021 Q2 | 324.64 Thousand CAD | 147.44% |
| 2021 Q3 | 457.72 Thousand CAD | 40.99% |
| 2021 Q4 | 838.35 Thousand CAD | 83.16% |
| 2020 FY | 262.8 Thousand CAD | 158.93% |
| 2020 Q2 | 3579.00 CAD | 1410.13% |
| 2020 Q3 | 126.47 Thousand CAD | 3433.7% |
| 2020 Q4 | 132.51 Thousand CAD | 4.78% |
| 2020 Q1 | 237.00 CAD | -99.61% |
| 2019 FY | 101.49 Thousand CAD | 0.0% |
| 2019 Q4 | 61.29 Thousand CAD | 106.88% |
| 2019 Q1 | 16.18 Thousand CAD | 833.77% |
| 2019 Q3 | -890.47 Thousand CAD | -197.37% |
| 2019 Q2 | 914.49 Thousand CAD | 5549.55% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q3 | 2206.00 CAD | 0.0% |
| 2018 Q4 | -2206.00 CAD | -200.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
| Asep Medical Holdings Inc | 21.14 Thousand CAD | -4726.982% |
| BetterLife Pharma Inc. | - CAD | -Infinity% |
| BioVaxys Technology Corp. | - CAD | -Infinity% |
| ChitogenX Inc. | - CAD | -Infinity% |
| Defence Therapeutics Inc. | - CAD | -Infinity% |
| Entheon Biomedical Corp. | 250.32 Thousand CAD | -307.643% |
| Gemina Laboratories Ltd. | - CAD | -Infinity% |
| Glow Lifetech Corp. | 43.93 Thousand CAD | -2222.788% |
| Lexston Life Sciences Corp. | - CAD | -Infinity% |
| Pharmala Biotech Holdings Inc. | 532 Thousand CAD | -91.808% |
| Doseology Sciences Inc. | 98.52 Thousand CAD | -935.732% |
| MYND Life Sciences Inc. | - CAD | -Infinity% |
| Nova Mentis Life Science Corp. | 28.34 Thousand CAD | -3499.887% |
| PharmaTher Holdings Ltd. | - CAD | -Infinity% |
| PreveCeutical Medical Inc. | - CAD | -Infinity% |
| Telescope Innovations Corp. | 595.39 Thousand CAD | -71.385% |